Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro

Fig. 1

TMZ and RG3 additively inhibited HUVEC proliferation. Cells were seeded in 24 well plates and treated with TMZ and/or RG3 for designated time and doses. a TMZ inhibited HUVEC proliferation in a time and dose dependent way. b RG3 inhibited HUVEC proliferation in a time and dose dependent way. c TMZ and RG3 additively inhibited proliferation of HUVECs. Bars with different letters indicate significant difference (P < 0.05) based on post-hoc Tukey analysis

Back to article page